Sort   by:  
 Page size 
UnknownOptimal target blood pressure in elderly with septic shock (OPTPRESS) trial: study protocol for a randomized controlled trial.
Not available
S-EPMC9509562 | biostudies-literature
UnknownAttenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Not available
S-EPMC8942852 | biostudies-literature
UnknownEnhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Not available
S-EPMC8828475 | biostudies-literature
UnknownMonitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay.
Not available
S-EPMC9510062 | biostudies-literature
UnknownComparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.
Not available
S-EPMC10366110 | biostudies-literature
UnknownVirological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Not available
S-EPMC10187524 | biostudies-literature
UnknownMultiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
Not available
S-EPMC10781145 | biostudies-literature
UnknownConvergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.
Not available
S-EPMC10175283 | biostudies-literature
UnknownAltered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Not available
S-EPMC8942856 | biostudies-literature
UnknownSARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Not available
S-EPMC8566220 | biostudies-literature
Sort   by:  
 Page size